EUA
Quaeris SARS-CoV-2 Assay
FDA Emergency Use Authorization · Harvard University Clinical Laboratory (HUCL) · Jul 8, 2021
Key facts
| Product | Quaeris SARS-CoV-2 Assay |
|---|---|
| Company | Harvard University Clinical Laboratory (HUCL) |
| Product type | Real-time RT-PCR, Home Collection, Multiple Targets |
| Date | Jul 8, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: